Dow Down 0.18% Nasdaq Down 0.31%

Celgene Corporation (CELG)

-NasdaqGS
94.67 Down 0.97(1.01%) 2:08PM EDT - Nasdaq Real Time Price
Prev Close:95.64
Open:95.39
Bid:94.38 x 500
Ask:94.42 x 400
1y Target Est:103.40
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.74 - 95.89
52wk Range:66.85 - 96.50
Volume:2,147,468
Avg Vol (3m):4,341,120
Market Cap:75.69B
P/E (ttm):54.72
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.01%75.69B
JNJUp 0.08%300.73B

Key Statistics

Forward P/E (1 yr):19.31
P/S (ttm):10.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback